HbA1c as indicator for dyslipidaemia, cardiovascular and atherosclerotic events in patients with metabolic syndrome. UTJsci [Internet]. 2015 Dec. 6 [cited 2024 Dec. 26];5(3):48-56. Available from: http://mail.jsci.utq.edu.iq/index.php/main/article/view/138